疫苗接种后原发性卵巢功能不全的自发报告:疫苗不良事件报告系统(VAERS)综述
该综述检索了美国被动监测系统VAERS中1990年1月1日至2017年12月31日所有疫苗接种后原发性卵巢功能不全(POI)报告,经临床审查应用ACOG诊断标准后,652份报告中有19份确定为POI,其中4份符合ACOG诊断标准;多数报告诊断信息有限且发表于HPV疫苗后POI病例报告之后,数据挖掘发现三个相关编码词在HPV疫苗接种后存在不成比例报告;作者认为结果不提示安全性担忧。
要点
- VAERS中POI报告罕见,652份检索报告经审查仅19份确定为POI。
- 19份报告中仅4份符合ACOG诊断标准,1份有明确病因(47XXX染色体异常)。
- 18/19份报告涉及HPV疫苗接种,多数报告在已发表HPV疫苗后POI病例之后提交。
核心结论
- POI在VAERS中罕见报告,多数报告诊断信息有限且在已发表HPV疫苗后POI病例之后提交,综述结果不提示安全性担忧。
研究设计与样本
- 检索美国被动监测系统VAERS中1990年1月1日至2017年12月31日收到的国内任何疫苗接种后POI报告,使用MedDRA首选术语和基于文本的POI及其症状检索,所有报告经临床审查并应用ACOG POI诊断指南,并进行不成比例报告的数据挖掘。
主要发现
- 652份报告符合检索标准,临床审查确定19份POI报告,其中16份在2013年至2017年间收到。
- 接种疫苗时中位年龄14.5岁(范围10-25岁),首次接种至向VAERS报告事件的中位间隔43个月(范围4-132个月;均值59.6个月)。
- 4份报告符合ACOG诊断标准,其中1份报告了潜在病因(47XXX染色体异常)。
- 11份报告记录月经不规则≥3个月,5份有≥1项用于诊断POI的实验室检查结果。
- 19份报告中18份描述接种HPV疫苗(伴或不伴其他疫苗),其他疫苗包括脑膜炎球菌结合疫苗、甲型肝炎疫苗、水痘疫苗和破伤风类毒素、减量白喉类毒素及无细胞百日咳疫苗;HPV疫苗接种后三个相关编码词发现不成比例报告。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since 2012, reports of primary ovarian insufficiency (POI) temporally associated with receipt of human papillomavirus (HPV) vaccine have been published leading to questions about a potential causal association. A Vaccine Safety Datalink study did not find an increased risk for POI after vaccination. We reviewed the Vaccine Adverse Event Reporting System (VAERS) to describe POI reports. METHODS: We searched VAERS, a U.S. passive surveillance system, for domestic POI reports received from 01/01/1990 to 12/31/2017 after any vaccination. The search used both Medical Dictionary for Regulatory Activity Preferred Terms and a text-based search for POI and its symptoms. All reports were reviewed, and the American College of Obstetricians and Gynecologists (ACOG) guidelines for POI diagnosis were applied. Data mining for disproportionate reporting was conducted. RESULTS: Six hundred fifty-two reports met the search criteria and clinical review identified 19 POI reports. Most reports (n = 16) were received between 2013 and 2017. The median age at vaccination was 14.5 years (range 10-25 years) and the median interval between first dose of vaccination and reporting the event to VAERS was 43 months (range 4-132 months; mean 59.6 months). Four reports met ACOG diagnostic criteria; one with an underlying cause (47XXX chromosomal abnormality) reported. Eleven reports documented menstrual irregularity ≥ 3 months; 5 had ≥ 1 laboratory test result used to diagnose POI. Eighteen of 19 reports described receipt of HPV vaccine with or without other vaccines. Other vaccines reported were meningococcal conjugate vaccine, hepatitis A, varicella and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis. Disproportionate reporting was found for three relevant coding terms after HPV vaccination. CONCLUSIONS: POI is rarely reported to VAERS. Most reports contained limited diagnostic information and were submitted after published cases of POI following HPV vaccination. Results of our review do not suggest a safety concern.
引用
- Patricia Wodi A, Marquez P, Mba-Jonas A, et al. Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS). Vaccine. 2023. PMID: 36732165. doi:10.1016/j.vaccine.2022.12.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。